Jarrett Jennifer — SEC insider filings
SEC reporting owner CIK 1671311. 55 insider filings on record with FilingPulse; latest filed 2026-09-28.
Transaction summary — filings shown
Covers the 50 most recent of 55 filings on record, filed 2021-06-15 to 2026-09-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 12,500 shares, $252,875 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 42 legs across 21 filings — 484,237 shares, $11,445,256 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 50.
- Largest priced transaction: sale of 50,291 shares @ $18.97 ($954,066) in Arcus Biosciences, Inc., filed 2025-11-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Arcus Biosciences, Inc. (RCUS) | Chief Operating Officer | 31 | — | 42 legs · 484,237 sh · $11,445,256 | 22 |
| Damora Therapeutics, Inc. (DMRA) | Director, President and CEO, Director | 2 | 1 leg · 12,500 sh · $252,875 | — | 2 |
| ARENA PHARMACEUTICALS INC (ARNA) | Director | 2 | — | — | 10 |
| Syndax Pharmaceuticals Inc (SNDX) | Director | 5 | — | — | 5 |
| Zura Bio Ltd (ZURA) | Director | 4 | — | — | 4 |
| Sagimet Biosciences Inc. (SGMT) | Director | 3 | — | — | 3 |
| Radius Health, Inc. (RDUS) | Director | 2 | — | — | 2 |
| Surrozen, Inc./DE (SRZN) | — | 1 | — | — | 2 |
Insider filings — Jarrett Jennifer
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-28 | 4 | Damora Therapeutics, Inc. (DMRA) | Purchase (P): 12,500 @ $20.23 | EDGAR |
| 2026-06-22 | 4 | Zura Bio Ltd (ZURA) | Grant/award (A): 51,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Sagimet Biosciences Inc. (SGMT) | Grant/award (A): 39,567 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Damora Therapeutics, Inc. (DMRA) | Grant/award (A): 500,000 @ $0 · Grant/award (A): 1,500,000 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Grant/award (A): 24,000 @ $0 | EDGAR |
| 2026-01-26 | 4 | Arcus Biosciences, Inc. (RCUS) | Grant/award (A): 31,000 @ $0 · Grant/award (A): 126,000 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 11,225 @ $21.88 · Sale (S): 9,983 @ $22.16 | EDGAR |
| 2025-11-12 | 4 | Arcus Biosciences, Inc. (RCUS) | Option exercise (M): 50,291 @ $1.23 · Sale (S): 50,291 @ $18.97 · Option exercise (M): 50,291 (derivative) @ $1.23 | EDGAR |
| 2025-10-08 | 4 | Arcus Biosciences, Inc. (RCUS) | Option exercise (M): 12,500 @ $1.23 · Sale (S): 12,500 @ $14.54 · Option exercise (M): 37,792 @ $1.23 · Sale (S): 37,792 @ $15.05 · Option exercise (M): 12,500 (derivative) @ $0 · Option exercise (M): 37,792 (derivative) @ $0 | EDGAR |
| 2025-06-10 | 4 | Sagimet Biosciences Inc. (SGMT) | Grant/award (A): 27,268 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | Zura Bio Ltd (ZURA) | Grant/award (A): 51,000 (derivative) @ $0 | EDGAR |
| 2025-02-07 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Grant/award (A): 25,000 @ $0 | EDGAR |
| 2025-01-27 | 4 | Arcus Biosciences, Inc. (RCUS) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2024-12-17 | 4 | Arcus Biosciences, Inc. (RCUS) | Tax withholding (F): 27,501 @ $16.08 | EDGAR |
| 2024-12-11 | 4 | Zura Bio Ltd (ZURA) | Grant/award (A): 117,000 (derivative) @ $0 | EDGAR |
| 2024-09-17 | 4 | Arcus Biosciences, Inc. (RCUS) | Tax withholding (F): 12,670 @ $17.95 | EDGAR |
| 2024-08-05 | 4 | Sagimet Biosciences Inc. (SGMT) | Grant/award (A): 113,895 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Arcus Biosciences, Inc. (RCUS) | Tax withholding (F): 12,670 @ $16.97 | EDGAR |
| 2024-03-29 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 11,551 @ $17.55 | EDGAR |
| 2024-03-20 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 12,153 @ $17.84 · Sale (S): 1,296 @ $18.62 | EDGAR |
| 2024-02-28 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 24,555 @ $20.07 · Sale (S): 34,070 @ $20.11 | EDGAR |
| 2024-02-09 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Grant/award (A): 17,000 @ $0 | EDGAR |
| 2024-01-25 | 4 | Arcus Biosciences, Inc. (RCUS) | Grant/award (A): 40,000 @ $0 · Grant/award (A): 162,400 (derivative) @ $0 | EDGAR |
| 2023-12-26 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 21,521 @ $17.76 | EDGAR |
| 2023-12-20 | 4 | Arcus Biosciences, Inc. (RCUS) | Disposition to issuer (D): 11,250 @ $17.74 · Disposition to issuer (D): 11,492 @ $18.09 | EDGAR |
| 2023-09-26 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 21,369 @ $19.99 | EDGAR |
| 2023-09-20 | 4 | Arcus Biosciences, Inc. (RCUS) | Disposition to issuer (D): 12,506 @ $20.40 | EDGAR |
| 2023-07-31 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 45,000 @ $20.25 | EDGAR |
| 2023-06-26 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 12,437 @ $19.12 | EDGAR |
| 2023-06-16 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 12,563 @ $19.35 | EDGAR |
| 2023-05-22 | 4 | Zura Bio Ltd (ZURA) | Grant/award (A): 7,652 (derivative) @ $0 | EDGAR |
| 2023-03-20 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 8,729 @ $16.81 | EDGAR |
| 2023-02-03 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Grant/award (A): 16,000 @ $0 | EDGAR |
| 2023-01-30 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 300 @ $23.56 · Sale (S): 1,600 @ $23.52 | EDGAR |
| 2023-01-25 | 4 | Arcus Biosciences, Inc. (RCUS) | Grant/award (A): 45,800 @ $0 · Grant/award (A): 185,900 (derivative) @ $0 | EDGAR |
| 2022-12-16 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 13,879 @ $30.66 · Sale (S): 2,603 @ $31.23 | EDGAR |
| 2022-09-20 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 12,677 @ $26.28 | EDGAR |
| 2022-08-15 | 4 | Radius Health, Inc. (RDUS) | Disposition to issuer (D): 30,000 (derivative) @ $4.16 | EDGAR |
| 2022-06-21 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 6,081 @ $20.72 · Sale (S): 1,951 @ $21.71 · Sale (S): 4,663 @ $22.29 | EDGAR |
| 2022-05-20 | 4 | Radius Health, Inc. (RDUS) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2022-03-18 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 9,617 @ $31.62 | EDGAR |
| 2022-03-11 | 4 | ARENA PHARMACEUTICALS INC (ARNA) | Other (J): 8,150 · Other (J): 3,067 · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +2 more | EDGAR |
| 2022-03-10 | 4 | Arcus Biosciences, Inc. (RCUS) | Grant/award (A): 31,250 @ $0 · Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2022-02-03 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Grant/award (A): 16,000 @ $0 | EDGAR |
| 2021-12-22 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 11,099 @ $40.88 · Sale (S): 20,923 @ $41.70 · Sale (S): 2,800 @ $42.23 | EDGAR |
| 2021-12-20 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 4,064 @ $39.59 · Sale (S): 1,496 @ $40.46 · Sale (S): 1,580 @ $38.79 · Sale (S): 1,008 @ $39.67 · Sale (S): 1,955 @ $40.57 · Sale (S): 2,575 @ $41.42 | EDGAR |
| 2021-09-22 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 8,134 @ $35.48 · Sale (S): 21,900 @ $35.06 · Sale (S): 600 @ $35.67 · Sale (S): 11,981 @ $35.50 · Sale (S): 4,885 @ $35.98 | EDGAR |
| 2021-08-13 | 4 | Surrozen, Inc./DE (SRZN) | Grant/award (A): 30,000 · Disposition to issuer (D): 30,000 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 3,809 @ $24.13 · Sale (S): 159 @ $24.77 · Sale (S): 4,863 @ $23.68 | EDGAR |
| 2021-06-15 | 4 | ARENA PHARMACEUTICALS INC (ARNA) | Grant/award (A): 3,067 @ $0 · Grant/award (A): 7,202 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1671311 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs